We are delighted to invite you to the International Invasive Lobular Breast Cancer (ILC) Virtual Symposium http://ilcsymposium.com/ to be held virtually on June 24th-25th, 2021 featuring special patient-advocate focused sessions June 23rd and June 30th.

The Symposium will include sessions focused on ILC biology, challenges in ILC diagnosis and treatment, and new avenues of ILC research and a discussion of opportunities for researchers, clinicians and advocates to work together to advance ILC research.  The featured keynote address by Christine Desmedt, PhD Katholieke Universiteit, Leuven Molecular is Features of Lobular Breast Cancer: Opportunities for Individualizing Therapy.  Sessions tailored specifically to patient advocates will cover basic information on ILC and discuss highlights of the symposium.

Registration is free and open to physicians, researchers, patient advocates and organizations interested in learning about ILC and the most current research to better understand this disease.  This virtual symposium replaces the 2020 International ILC symposium, cancelled due to the pandemic.

This symposium will be an opportunity to share current research in ILC and continue to build a vibrant, collaborative community of physicians, researchers, and advocates, ultimately impacting outcomes for patients with ILC. We encourage you to participate in these discussions and to voice your ideas and suggestions as we plan future projects.

Go to http://ilcsymposium.com/ to see the full agenda and to register.  We anticipate that most of the sessions will be recorded and available to registrants who cannot participate real-time.

Looking forward to ‘seeing’ you there,

Patrick & Christine
Also on behalf of the co-organizers Steffi Oesterreich & Otto Metzger